LivaNova PLC (LIVN) stock
LIVNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/3032% above fair value
$94.54+2.62 (+2.85%)
Close on Nov 18, 2026Market cap $5.21BP/E 27.9Yield –
LivaNova enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
LivaNova's enterprise value was $4.79B on Nov 11, 2026, against $3.27B a year earlier. Over the last 5 years it ranged from $1.91B to $4.79B, with a median of $3.01B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $4.79B | +52.0% |
| 2025 | Dec 31, 2025 | $3.15B | +27.2% |
| 2024 | Dec 31, 2024 | $2.47B | -12.9% |
| 2023 | Dec 29, 2023 | $2.84B | -5.5% |
| 2022 | Dec 30, 2022 | $3.01B | -36.2% |
| 2021 | Dec 31, 2021 | $4.71B | +29.4% |
| 2020 | Dec 31, 2020 | $3.64B | -7.1% |
| 2019 | Dec 31, 2019 | $3.92B | -13.5% |
| 2018 | Dec 31, 2018 | $4.53B | +15.8% |
| 2017 | Dec 29, 2017 | $3.91B | +274.3% |
| 2016 | Dec 30, 2016 | $1.04B | -26.4% |
| 2015 | Dec 31, 2015 | $1.42B | +7.2% |
| 2014 | Dec 31, 2014 | $1.32B | -19.6% |
| 2013 | Dec 31, 2013 | $1.65B | – |
See a number that looks wrong?